Adenosine a2a receptor antagonists for the treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/06 (2006.01)

Patent

CA 2625859

There is disclosed a method for the treatment or prevention of Extra Pyramidal syndrome (EPS), dystonia, restless legs syndrome (RLS) or periodic leg movement in sleep (PLMS) comprising the administration of an adenosine A2a receptor antagonist, alone or in combination with other agents useful for treating EPS, dystonia, RLS or PLMS; also claimed are pharmaceutical compositions consisting of an adenosine A2a receptor antagonist in combination with an antipsychotic agent, an anticonvulsant agent, lithium or an opioid.

L'invention concerne une méthode de traitement ou de prévention du syndrome extrapyramidal (EPS), de la dystonie, du syndrome des jambes sans repos (RLS) ou des mouvements périodiques des jambes pendant le sommeil (PLMS), qui consiste à administrer un antagoniste du récepteur A2a de l'adénosine, seul ou associé à d'autres agents utilisés dans le traitement de l'EPS, de la dystonie, du RLS ou des PLMS. De plus, l'invention concerne des compositions pharmaceutiques qui renferment un antagoniste du récepteur A2a de l'adénosine associé à un agent antipsychotique, un agent anticonvulsif, du lithium ou un opioïde.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adenosine a2a receptor antagonists for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenosine a2a receptor antagonists for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine a2a receptor antagonists for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1528877

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.